Figure 9 : The effects of imeglimin (0.05, 0.1, or 0.25 mmol•L-1) on insulin secretion in the perfused pancreas were investigated as described in Methods. Values are mean (SEM). Imeglimin had no effect in insulin secretion in the absence of glucose but showed strong potentiation of first-phase glucose-induced insulin secretion.